Results 61 to 70 of about 1,630,140 (194)

Italian Multicenter Study on Low-Density Lipoprotein Apheresis Working Group 2009 Survey

open access: yes, 2013
We present results of the second survey of the Italian Multicenter Study on Low-Density Lipoprotein Apheresis (IMSLDLa-WG/2). The study involved 18 centers in 2009, treating 66 males and 35 females, mean age 47 +/- 18 years.
MOROZZI, CLAUDIA   +3 more
core   +1 more source

Therapeutic apheresis in peripheral and retinal circulatory disorders. [PDF]

open access: yes, 2012
In microcirculation disorders, the therapeutic apheresis seems to have two different effects. The first, achieved after only a few sessions, is acute, consisting of drastic reduction of blood viscosity and obtained with the use of low-density lipoprotein
De Fino G   +9 more
core   +1 more source

S1 Guideline: Therapy of generalized pustular psoriasis

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary The S1 guideline “Therapy of generalized pustular psoriasis (GPP)” is a German guideline developed in accordance with the criteria of the AWMF. The full version addresses clinical presentation, pathogenesis, diagnosis and differential diagnosis, comorbidities, and therapy.
Rotraut Mößner   +17 more
wiley   +1 more source

Plasmapheresis Activity of a Tertiary Referral Centre Indicating Wide-Spread Interdisciplinary and Safe Use of Therapeutic Plasma Exchange, with an Emphasis on Thrombotic Thrombocytopenic Purpura

open access: yesCam & Sakura Medical Journal
Objective: This study aimed to evaluate the clinical spectrum, treatment characteristics, and outcomes of therapeutic apheresis (TA) procedures performed at a tertiary care university hospital, with particular emphasis on thrombotic thrombocytopenic ...
Berrin Balık   +4 more
doaj   +1 more source

Therapeutic apheresis in low weight patients: Technical feasibility, tolerance, compliance, and risks

open access: yes, 2004
The use of therapeutic apheresis in very low weight patients is generally thought to have limitations, because of possible severe adverse reactions, potential risk related to the extracorporeal procedure, due to the low weight of the young patients.
DE LORENZO, FABRIZIO   +6 more
core   +2 more sources

Preventing infections after CD19‐directed chimeric antigen receptor T‐cell therapies for lymphoma: a consensus practice statement

open access: yesInternal Medicine Journal, EarlyView.
Abstract Chimeric antigen receptor (CAR) T‐cell therapies directed against cluster of differentiation 19 (CD19) are a standard of care for relapsed or refractory B‐cell lymphomas. Infection is the leading cause of non‐relapse mortality, and this risk may persist for years after CAR T‐cell receipt.
Aine Hurley   +15 more
wiley   +1 more source

Distribution of indications and procedures within the framework of centers participating in the WAA apheresis registry

open access: yes, 2017
The WAA apheresis registry was established in 2003 and an increasing number of centers have since then included their experience and data of their procedures.
Wahlstrom, A   +89 more
core   +1 more source

Understanding Exosomes in Hair Regeneration

open access: yesPeriodontology 2000, EarlyView.
Abstract Background Alopecia is a prevalent condition correlated with significant psychosocial challenges, while contemporary treatments exhibit variable efficacy, require extended use, and may cause adverse effects. This review aimed to comprehensively assess exosome‐mediated interventions as a novel cell‐free regenerative approach for hair ...
Paras Ahmad   +3 more
wiley   +1 more source

An Annual Review of Important Apheresis Articles From the American Society for Apheresis Attending Physician Subcommittee

open access: yes
In this first annual review article, the American Society for Apheresis (ASFA) Attending Physician Subcommittee (APSc) of the Physicians' Committee (PC) curated key apheresis literature in 2023 and presented their choices for the 10 most seminal ...
Alsammak, Mohamed   +15 more
core   +1 more source

Therapeutic plasma exchange in glucocorticosteroid-unresponsive patients with Clinically Isolated Syndrome

open access: yes, 2022
S.489-496Clinically Isolated Syndromes (CIS) summarize clinical features of possible multiple sclerosis (MS) as a first clinical event of the disease. Escalation therapy in CIS episodes comprises high dose glucocorticosteroid (GCS) treatment followed by ...
Mitzner, Steffen   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy